Moments in
Dual Anti-Platelet Therapy

Go Back
CRT 2016 Coronary - Antiplatelet Controversies for ACS: How Will They Impact Our Practice?
Conference
Antiplatelet Controversies for ACS: 'How Will They Impact Our Practice?' at CRT 2016
CRT 2016 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate
Conference
Session on Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate at CRT 2016
CRT 2016 Coronary - CTO Academy - Best Abstracts
Conference
CTO Academy - Best Abstracts at CRT 2016
CRT 2015 Coronary - Antiplatelet Controversy For ACS: How will this iMPACT our Practice?
Conference
A session on Antiplatelet Controversy For ACS and How this will iMPACT a Practice, from CRT 2015.
CRT 2015 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate
Conference
A session on Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate at CRT 2015
CRT 2015 - Satellite Symposium: Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI
Conference
A session on Novel Therapeutic Pathways in the Secondary Prevention of Atherothrombotic Events in AMI from CRT 2015
Supported By
CRT 2015 Coronary - Complex Coronary Interventions II
Conference
A session on Complex Coronary Interventions II from CRT 2015
CRT 2016 Endovascular - Optimization of Anticoagulation for STEMI Therapy
Conference
A session on Optimization of Anticoagulation for STEMI Therapy from CRT 2016
CRT 2017 : DES BIOABSORBABLE & DCB TECHNOLOGIES - DES Thrombosis Restenosis and DAPT Duration
Conference
CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients
Conference
CRT 2017 : Late Breaking Trials: Session I
Conference
CRT 2017 : Optimization of Anticoagulation for STEMI Therapy - Supported by educational grants from AstraZenca, Chiesi USA, Inc. and Medicure, Inc.
Conference
Loading Simple Education